Refine
Year of publication
Document Type
- Article (59)
- Book (1)
- Working Paper (1)
Has Fulltext
- yes (61)
Is part of the Bibliography
- no (61)
Keywords
- liver transplantation (3)
- COVID-19 (2)
- Cancer treatment (2)
- Hepatocellular carcinoma (2)
- cirrhosis (2)
- treatment (2)
- ALK-rearranged NSCLC (1)
- Accelerators & Beams (1)
- Accelerators & storage rings (1)
- Alzheimer’s dementia (1)
- Amyloid-beta 42 (1)
- Aneurysmal subarachnoid hemorrhage (1)
- Atomic & molecular beams (1)
- Atomic, Molecular & Optical (1)
- Autologous stem cell transplantation (1)
- Beam loss (1)
- Biomarkers (1)
- Blood-brain barrier (1)
- Cancer (1)
- Cancer chemotherapy (1)
- Cancer genetics (1)
- Cancer genomics (1)
- Charge-transfer collisions (1)
- Chemotherapy (1)
- Chronic kidney disease (1)
- Circular accelerators (1)
- Clinical genetics (1)
- Colorectal cancer (1)
- Common Agricultural Policy (1)
- Complications (1)
- Computed axial tomography (1)
- Computerlinguistik (1)
- DST (1)
- Data sharing (1)
- Dialog (1)
- Digestive system (1)
- Digestive system procedures (1)
- Drug susceptibility testing (1)
- EP300 (1)
- ETP-ALL (1)
- EWSR1 (1)
- Electronic transitions (1)
- Endoscopy (1)
- Enterostomy (1)
- Enterostomy closure (1)
- Enterostomy formation (1)
- Epidemiology (1)
- Estimated glomerular filtration rate (1)
- European Green Deal (1)
- Extended Glasgow outcome scale (eGOS) (1)
- Extended donor criteria (1)
- FLT3 (1)
- FOXO1 (1)
- Fibrotest (1)
- Forschung (1)
- Gastric cancer (1)
- Gene fusion (1)
- Genomic instability (1)
- Germany (1)
- HCC (1)
- HCV (1)
- HIV (1)
- HNO (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hepatotoxicity (1)
- High-dose chemotherapy (1)
- Hippocampal volume (1)
- IgG4-related disease (1)
- Ileostomy (1)
- Immune suppression (1)
- Immunology (1)
- Incidence (1)
- Indeterminate biliary stricture (1)
- Interventional oncological treatment (1)
- Intestinal neoplasms (1)
- Laser interstitial thermal therapy (1)
- Lehre (1)
- Lenalidomide (1)
- Lesion (1)
- Liver diseases (1)
- Liver enzymes (1)
- Liver transplantation (1)
- Long term output (1)
- Low & intermediate-energy accelerators (1)
- Lung Cancer (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- Magnetic resonance imaging (MRI) (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Microwave ablation (1)
- Mild cognitive impairment (1)
- Molecular medicine (1)
- Multiple myeloma (1)
- NOTCH1 (1)
- NTM (1)
- Necrotizing enterocolitis (1)
- Neonates (1)
- Neuroepithelial tumor (1)
- Non-small cell lung cancer (1)
- Non-tuberculous mycobacteria (1)
- Nuclear astrophysics (1)
- Nuclear physics of explosive environments (1)
- Nuclear reactions (1)
- ORL (1)
- Older patient (1)
- Oncogenes (1)
- Organ allocation (1)
- Otorhinolaryngology (1)
- PLAGL1 (1)
- Pancreas transplantation (1)
- Phospho-tau (1)
- Photon counting (1)
- Prediction (1)
- Prognosis (1)
- Psychiatric disorders (1)
- ROS1 (1)
- Radiation exposure (1)
- Radiative capture (1)
- Rectal cancer (1)
- Regression analysis (1)
- Rejection (1)
- Relapse (1)
- Research (1)
- Residency (1)
- SARS-CoV (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SMART targets (1)
- Sarcopenia (1)
- Second-line treatment (1)
- Self-expandable metal stents (1)
- Self-expandable metal stents complications (1)
- Specialist training (1)
- Stoma (1)
- Supratentorial (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- T-ALL (1)
- TACE (1)
- TP53 mutation status (1)
- Tau (1)
- Teaching (1)
- Thrombotic microangiopathy (1)
- Thrombotic thrombocytopenic purpura (1)
- Transarterial chemoembolization (1)
- Transient elastography (1)
- Tumor obstruction (1)
- University hospitals (1)
- Universitätskliniken (1)
- Weiterbildung (1)
- acute lymphoblastic leukemia (1)
- agriculture (1)
- anti-EGFR therapy (1)
- antimicrobial stewardship (1)
- bile duct stenosis (1)
- biliary stricture (1)
- biodiversity (1)
- cART (1)
- carbapenem resistance (1)
- central nervous system infection (1)
- chemorefractory metastatic colorectal cancer (1)
- climate change (1)
- co-infection (1)
- death rates (1)
- diagnosis (1)
- endoscopic retrograde cholangiopancreatography (1)
- endoscopy (1)
- enterobacter infections; pseudomonas aeruginosa; epidemiology (1)
- eosinophilic cholangitis (1)
- epidemiology (1)
- evidence-based policy (1)
- global change (1)
- guideline (1)
- habitat destruction (1)
- hepatocellular carcinoma (1)
- immunocompromised patient (1)
- infection control (1)
- intraperitoneal therapy (1)
- land use (1)
- medical risk factors (1)
- molecular characteristics (1)
- multidrug resistance (1)
- neurocritical care (1)
- overall survival (1)
- pandemic (1)
- patient triage (1)
- perioperative mortality (1)
- peritoneal carcinomatosis (1)
- platelet count (1)
- portal hypertension (1)
- pressurized intraperitoneal aerosol chemotherapy (PIPAC) (1)
- primary sclerosing cholangitis (1)
- pseudomonas aeruginosa (1)
- public goods (1)
- re-exposure (1)
- rechallenge (1)
- recurrent cholangitis (1)
- reintroduction (1)
- sequential ALK-inhibitor therapy (1)
- short-course antibiotic therapy (1)
- sorafenib (1)
- thrombocytopenia (1)
- thrombocytosis (1)
- transmission (1)
- upper gastrointestinal cancer (1)
- whole-genome sequencing (1)
- x-ray techniques (1)
Institute
Background and aims: Patients with gastric cancer often show signs of malnutrition. We sought to evaluate the influence of sarcopenia in patients with locally advanced, not metastasized, gastric or gastro-esophageal junction (GEJ) cancer undergoing curative treatment (perioperative chemotherapy and surgery) on morbidity and mortality in order to identify patients in need for nutritional intervention.
Patients and methods: Two-centre study, conducted in the Frankfurt University Clinic and Krankenhaus Nordwest (Frankfurt) as part of the University Cancer Center Frankfurt (UCT). 47/83 patients were treated in the FLOT trial (NCT01216644). Patients´ charts were reviewed for clinical data. Two consecutive CT scans were retrospectively analyzed to determine the degree of sarcopenia. Survival was calculated using the Kaplan-Meier method, multivariate analysis was performed using the Cox regression.
Results: 60 patients (72.3%) were male and 23 (27.7%) female. 45 patients (54.2%) had GEJ type 1–3 and 38 (45.8%) gastric tumors, respectively. Sarcopenic patients were significantly older than non-sarcopenic patients (mean age 65.1 years vs. 59.5 years, p = 0.042), terminated the chemotherapy significantly earlier (50% vs. 22.6%, p = 0.037) and showed higher Clavien-Dindo scores, indicating more severe perioperative complications (score ≥3 43.3 vs. 17.0%, p = 0.019). Sarcopenic patients had a significantly shorter survival than non-sarcopenic patients (139.6 ± 19.5 [95% CI, 101.3–177.9] vs. 206.7 ± 13.8 [95% CI, 179.5–233.8] weeks, p = 0.004). Multivariate Cox regression analysis showed that, besides UICC stage, sarcopenia significantly influenced survival.
Conclusion: Sarcopenia is present in a large proportion of patients with locally advanced gastric or GEJ cancer and significantly influences tolerability of chemotherapy, surgical complications and survival.